Everence Capital Management’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
Everence Capital Management's MDLN Position: Q3 2026 in Review
Everence Capital Management sold out of Medline (MDLN) in Q3 2026, closing a stake of 28,161 shares — an estimated $1.11M sold.
Everence Capital Management first reported a position in MDLN in Q1 2026 and held it in 2 quarters. The position peaked at $1.11M in Q2 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.
- Everence Capital Management reported no remaining Medline position as of Q3 2026 after selling out during the quarter.
- Everence Capital Management sold 28,161 Medline shares in Q3 2026, an estimated $1.11M.
- Everence Capital Management first reported a position in Medline in Q1 2026 and held it in 2 quarters.
- Everence Capital Management's Medline position peaked at $1.11M in Q2 2026.
- 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.
Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.